- Home >
- Life Sciences >
- Pharmaceutical >
MarketWatch: Biotechnology
MarketWatch: Biotechnology
- Report price : $ 200
- Publication date : October 2008
- Length : 28 pages
MarketWatch: Biotechnology
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.
RELATED REPORTS
MarketWatch: CNS
- $ 200
- October 2008
- 25 pages
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in theCN ...
Industries : Pharmaceutical
MarketWatch: Cancer
- $ 200
- October 2008
- 27 pages
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventu ...
Industries : Pharmaceutical
MarketWatch: Health Round-up
- $ 400
- October 2008
- 46 pages
Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory an ...
Industries : Pharmaceutical
Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
- $ 15 200
- September 2008
IntroductionThe antidyslipidemic market is expected to fall to $20 billion in 2017. The decline will be driven by the deep genericization of the market, further exacerbated by the patent expiries of the top antidyslipidemic, Pfizer's Lipitor, as well as by the recent negative messages from the ILLUM ...
Industries : Pharmaceutical
Celgene Corporation: PharmaVitae Profile
- $ 5 700
- September 2008
- 133 pages
IntroductionThis analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An ...
Industries : Pharmaceutical
Stakeholder Insight: Osteoporosis - Generic alendronate further establishes oral bisphosphonates as gold standard
- $ 15 200
- October 2008
- 199 pages
IntroductionAlmost 100 million post-menopausal women suffer from osteopenia and osteoporosis in the seven major markets. Those diagnosed are often identified through screening for low bone mineral density or after presenting with a fracture. Although not all guidelines are clear on when to initiate ...
Industries : Pharmaceutical
Sales Force Effectiveness
- $ 7 600
- September 2008
- 91 pages
IntroductionThe traditional sales force model is no longer effective as doctors are no longer the key prescribing decision makers. Governments and payers are implementing cost cutting initiatives and promoting generic use in an attempt to control escalating healthcare costs. This has made it increas ...
Industries : Pharmaceutical
Financial Deals Industry Tracker: Pharmaceuticals and Healthcare August 2008 (analysis of merger and acquisition (M&A), private equity, venture financing, private placement, initial public offering (IPO), and secondary offering deals)
- $ 495
- September 2008
- 50 pages
SynopsisAnalysis and opinion on monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, private placement, IPO, and secondary offering deals.IntroductionThis report contains extensive qualitative and quantitative analysis of monthly deal ...
Industries : Pharmaceutical
Indian Aesthetic (Cosmetic Surgery) Industry: A Primer
- $ 2 500
- May 2008
- 150 pages
Cosmetic surgery has been practiced in India for a long time but this branch of plastic surgery gained considerable importance and popularity in the last 10-12 years. There has been a notable surge in the Indian cosmetic or aesthetic surgery during the past five years mainly because of the increasin ...
Industries : Pharmaceutical
World Pharmaceuticals Market Brief
- $ 1 950
- September 2008
- 425 pages
The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report provides a bird’s eye view of the pharmaceutical industry, and highlights global trends impacting the marketplace, such as, patent expi ...
Industries : Pharmaceutical
Related industries
reportlinker.com © Copyright 2009. All rights reserved